Valeo Financial Advisors, LLC - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 359 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
Valeo Financial Advisors, LLC ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$5,000102
+1940.0%
0.00%
Q4 2020$0
-100.0%
5
-66.7%
0.00%
Q2 2020$1,0000.0%150.0%0.00%
Q1 2020$1,0000.0%150.0%0.00%
Q4 2019$1,0000.0%150.0%0.00%
Q3 2019$1,000
-66.7%
15
-76.6%
0.00%
Q4 2018$3,0000.0%640.0%0.00%
Q3 2018$3,0000.0%640.0%0.00%
Q2 2018$3,000
-91.9%
64
-92.4%
0.00%
-100.0%
Q1 2018$37,0008460.01%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Bellevue Group AG 9,930,245$396,117,0003.87%
Sicart Associates LLC 368,409$14,696,0003.50%
Camber Capital Management LP 2,000,000$79,780,0002.69%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 181,781$7,251,0001.91%
SECTOR GAMMA AS 263,488$10,511,0001.86%
Parkman Healthcare Partners LLC 136,380$5,440,0001.19%
Eversept Partners, LP 442,000$17,631,3801.18%
Affinity Asset Advisors, LLC 75,000$2,992,0001.07%
TANAKA CAPITAL MANAGEMENT INC 16,661$665,0000.90%
Sonora Investment Management, LLC 168,665$6,728,0000.88%
View complete list of IONIS PHARMACEUTICALS INC shareholders